Qingfeng He

1.4k total citations
76 papers, 1.1k citations indexed

About

Qingfeng He is a scholar working on Molecular Biology, Pharmacology and Infectious Diseases. According to data from OpenAlex, Qingfeng He has authored 76 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 18 papers in Pharmacology and 8 papers in Infectious Diseases. Recurrent topics in Qingfeng He's work include Pharmacogenetics and Drug Metabolism (13 papers), Drug-Induced Hepatotoxicity and Protection (7 papers) and Antibiotics Pharmacokinetics and Efficacy (5 papers). Qingfeng He is often cited by papers focused on Pharmacogenetics and Drug Metabolism (13 papers), Drug-Induced Hepatotoxicity and Protection (7 papers) and Antibiotics Pharmacokinetics and Efficacy (5 papers). Qingfeng He collaborates with scholars based in China, United States and Malaysia. Qingfeng He's co-authors include Donghui Liang, Rong Chen, Hao Yang, Zhong Lu, Jie Wu, Pingli Li, Chunming Tang, Yanjie Li, Haoyun Wu and Xiaoqiang Xiang and has published in prestigious journals such as Advanced Drug Delivery Reviews, Biochemical and Biophysical Research Communications and FEBS Letters.

In The Last Decade

Qingfeng He

67 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qingfeng He China 16 265 244 188 175 159 76 1.1k
Thanaa I. Shalaby Egypt 18 206 0.8× 231 0.9× 139 0.7× 156 0.9× 35 0.2× 58 1.1k
Mohammadreza Abbaspour Iran 26 203 0.8× 365 1.5× 331 1.8× 40 0.2× 80 0.5× 99 1.9k
Sanjeeb Kalita India 22 337 1.3× 347 1.4× 211 1.1× 57 0.3× 45 0.3× 35 1.4k
Hussnain Ahmed Janjua Pakistan 19 180 0.7× 104 0.4× 417 2.2× 50 0.3× 60 0.4× 59 1.1k
Emilia Szymańska Poland 16 317 1.2× 683 2.8× 231 1.2× 54 0.3× 32 0.2× 36 1.8k
Sharadwata Pan Germany 19 259 1.0× 101 0.4× 280 1.5× 72 0.4× 103 0.6× 42 1.1k
Marcílio Cunha‐Filho Brazil 31 425 1.6× 295 1.2× 415 2.2× 47 0.3× 32 0.2× 154 2.8k
Danina Krajišnik Serbia 23 118 0.4× 237 1.0× 149 0.8× 205 1.2× 54 0.3× 57 1.3k
Tahir Ahmad Pakistan 17 275 1.0× 690 2.8× 166 0.9× 36 0.2× 25 0.2× 52 1.5k

Countries citing papers authored by Qingfeng He

Since Specialization
Citations

This map shows the geographic impact of Qingfeng He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingfeng He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingfeng He more than expected).

Fields of papers citing papers by Qingfeng He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qingfeng He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingfeng He. The network helps show where Qingfeng He may publish in the future.

Co-authorship network of co-authors of Qingfeng He

This figure shows the co-authorship network connecting the top 25 collaborators of Qingfeng He. A scholar is included among the top collaborators of Qingfeng He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qingfeng He. Qingfeng He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Xin, Lulu Chen, Xintong Wang, et al.. (2025). Parametric Population Pharmacokinetics Model Repository of Rifampicin: Model-Informed Individualized Therapy. Clinical Pharmacology Advances and Applications. Volume 17. 49–78. 1 indexed citations
2.
Shi, Xiao‐Ping, Qing Xu, Xiaoyu Li, et al.. (2025). Population pharmacokinetics and thrombocytopenia risk assessment of linezolid in liver transplant recipients. Journal of Antimicrobial Chemotherapy. 80(7). 1915–1925.
4.
Guo, Nan, et al.. (2025). Cost–utility analysis of sotagliflozin for heart failure patients with diabetes in China. British Journal of Clinical Pharmacology. 1 indexed citations
5.
Mak, Wen Yao, et al.. (2025). PBPK Modeling: Empowering Drug Development and Precision Dosing in China. CPT Pharmacometrics & Systems Pharmacology. 14(5). 828–839. 1 indexed citations
6.
Zhou, Hangyu, Xuan Tong, Xiaodong Ma, et al.. (2025). A loofah-like porous tubular g-C3N4 nanoreactors for the photocatalytic degradation of various dyes and antibiotics. Journal of Alloys and Compounds. 1026. 180414–180414. 4 indexed citations
7.
He, Qingfeng, Min Li, Yao Li, et al.. (2024). Comparison of drug-induced liver injury risk between propylthiouracil and methimazole: A quantitative systems toxicology approach. Toxicology and Applied Pharmacology. 491. 117064–117064. 2 indexed citations
8.
Wei, Shengjie, Le Zhang, Haiyang Xu, et al.. (2024). Photo-assisted electrocatalysis of NiO/CeO2 heterojunction for efficient oxygen evolution reaction. Molecular Catalysis. 557. 113984–113984. 3 indexed citations
9.
Tang, Xiao, Chuan Xie, Jing Zeng, et al.. (2024). HPV genotypes in invasive cervical cancer: prevalence, risk attribution, and optimized vaccine strategies in western China. Frontiers in Public Health. 12. 1455931–1455931. 1 indexed citations
10.
Mak, Wen Yao, Yue Wu, Qingfeng He, et al.. (2024). Development and Quality Control of a Population Pharmacokinetic Model Library for Caspofungin. Pharmaceutics. 16(6). 819–819. 1 indexed citations
11.
Wu, Dan, Jiang Pin, Qingfeng He, et al.. (2024). Physiologically Based Pharmacokinetic Modeling and Clinical Extrapolation for Topical Application of Pilocarpine on Eyelids: A Comprehensive Study. Journal of Pharmaceutical Sciences. 113(9). 2861–2870. 2 indexed citations
13.
Mak, Wen Yao, Amanda Gwee, Yue Wu, et al.. (2023). Establishment and Evaluation of a Parametric Population Pharmacokinetic Model Repository for Ganciclovir and Valganciclovir. Pharmaceutics. 15(7). 1801–1801. 8 indexed citations
14.
Li, Zhihong, Ke Wang, Qingfeng He, et al.. (2023). Pharmacokinetics of Novel Furoxan/Coumarin Hybrids in Rats Using LC-MS/MS Method and Physiologically Based Pharmacokinetic Model. Molecules. 28(2). 837–837. 1 indexed citations
15.
Ji, Xiwei, et al.. (2023). Foretinib Is Effective against Triple-Negative Breast Cancer Cells MDA-MB-231 In Vitro and In Vivo by Down-Regulating p-MET/HGF Signaling. International Journal of Molecular Sciences. 24(1). 757–757. 2 indexed citations
16.
Yu, Yiqun, Hongrui Liu, Qingfeng He, et al.. (2023). Prediction of Drug–Drug Interactions with Ensartinib as a Time-Dependent CYP3A Inhibitor Using Physiologically Based Pharmacokinetic Model. Drug Metabolism and Disposition. 51(11). 1515–1526. 2 indexed citations
17.
Li, Min, et al.. (2022). Applications of In Silico Models to Predict Drug-Induced Liver Injury. Toxics. 10(12). 788–788. 12 indexed citations
18.
He, Qingfeng, et al.. (2022). Utilization of Physiologically Based Pharmacokinetic Modeling in Pharmacokinetic Study of Natural Medicine: An Overview. Molecules. 27(24). 8670–8670. 6 indexed citations
19.
Ji, Xiwei, Xiangrui Meng, Xiao Zhu, Qingfeng He, & Yimin Cui. (2022). Research and development of Chinese anti-COVID-19 drugs. Acta Pharmaceutica Sinica B. 12(12). 4271–4286. 17 indexed citations
20.
He, Qingfeng. (2009). Study on Productive Endocrine System Toxicity of Subchronic Cadmium Exposure in Female Rats. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026